Tough Gets Tougher For Global Firms And Indian Giants
This article was originally published in The Pink Sheet Daily
Executive Summary
An industry update by Indian credit rating agency ICRA finds global drug makers saw their profitability drop in the country mainly due to a drying up of launch plans, while their Indian counterparts are contending for scale with bigger global generic rivals.